Onconova Therapeutics Inc (NASDAQ:ONTX)
| 0.7136 Delayed Data As of Jan 22 |  -0.0295 / -3.97%Today’s Change | 0.19 Today|||52-Week Range 1.56 | +53.20% Year-to-Date |
Latest ONTX News | Press Releases
No recent news for Onconova Therapeutics Inc.
Today’s Trading
| Previous close | 0.74 |
| Today’s open | 0.74 |
| Day’s range | 0.70 - 0.74 |
| Volume | 384,089 |
| Average volume (3 months) | 23,127,091 |
| Market cap | $169.2M |
Data as of 7:20pm ET, 01/22/2021
Growth & Valuation
| Earnings growth (last year) | +70.03% |
| Earnings growth (this year) | +90.60% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +77.77% |
| P/E ratio | 0.7 |
| Price/Sales | 2.52 |
| Price/Book | 7.86 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LPCNLipocine Inc | -0.04 | -1.75% |
| ORMPOramed Pharmaceutica... | +0.92 | +20.09% |
| COCPCocrystal Pharma Inc | -0.11 | -4.98% |
| EYPTEyePoint Pharmaceuti... | +0.03 | +0.30% |
Data as of 4:42pm ET, 01/22/2021
Financials
| Next reporting date | March 29, 2021 |
| EPS forecast (this quarter) | -$0.03 |
| Annual revenue (last year) | $2.2M |
| Annual profit (last year) | -$21.5M |
| Net profit margin | -985.02% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Newtown, Pennsylvania |
Forecasts
